Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diabetes

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    April 2024
  1. DE GEORGE DJ, Jhala G, Selck C, Trivedi P, et al
    Altering beta Cell Antigen Exposure to Exhausted CD8+ T Cells Prevents Autoimmune Diabetes in Mice.
    J Immunol. 2024 Apr 8:ji2300785. doi: 10.4049/jimmunol.2300785.
    PubMed     Abstract available


    March 2024
  2. RACINE JJ, Bachman JF, Zhang JG, Misherghi A, et al
    Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti-PD-1 Immune Checkpoint Inhibitor Cancer Therapy.
    J Immunol. 2024 Mar 1:ji2300841. doi: 10.4049/jimmunol.2300841.
    PubMed     Abstract available


  3. COSTANZO A, Clarke D, Holt M, Sharma S, et al
    Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature.
    J Immunol. 2024 Mar 1:ji2300769. doi: 10.4049/jimmunol.2300769.
    PubMed     Abstract available


    January 2024
  4. KLUG N, Burke J, Scott E
    Rational Engineering of Islet Tolerance via Biomaterial-Mediated Immune Modulation.
    J Immunol. 2024;212:216-224.
    PubMed     Abstract available


    December 2023
  5. FOER D, Amin T, Nagai J, Tani Y, et al
    Glucagon-like Peptide-1 Receptor Pathway Attenuates Platelet Activation in Aspirin-Exacerbated Respiratory Disease.
    J Immunol. 2023;211:1806-1813.
    PubMed     Abstract available


    October 2023
  6. RACINE JJ, Misherghi A, Dwyer JR, Maser R, et al
    HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice.
    J Immunol. 2023 Oct 25:ji2300303. doi: 10.4049/jimmunol.2300303.
    PubMed     Abstract available


  7. GILLES A, Hu L, Virdis F, Sant'Angelo DB, et al
    The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.
    J Immunol. 2023 Oct 9:ji2300213. doi: 10.4049/jimmunol.2300213.
    PubMed     Abstract available


    September 2023
  8. NEW JS, Dizon BLP, King RG, Greenspan NS, et al
    B-1 B Cell-Derived Natural Antibodies against N-Acetyl-d-Glucosamine Suppress Autoimmune Diabetes Pathogenesis.
    J Immunol. 2023 Sep 25:ji2300264. doi: 10.4049/jimmunol.2300264.
    PubMed     Abstract available


    May 2023
  9. WU F, Wei H, Hu Y, Gao J, et al
    Upregulation of P2X7 Exacerbates Myocardial Ischemia-Reperfusion Injury through Enhancing Inflammation and Apoptosis in Diabetic Mice.
    J Immunol. 2023 May 5:ji2200838. doi: 10.4049/jimmunol.2200838.
    PubMed     Abstract available


    March 2023
  10. ZHANG X, Ohayon-Steckel L, Coppin E, Johny E, et al
    Epidermal Growth Factor Receptor in Hepatic Endothelial Cells Suppresses MCP-1-Dependent Monocyte Recruitment in Diabetes.
    J Immunol. 2023 Mar 22:ji2200557. doi: 10.4049/jimmunol.2200557.
    PubMed     Abstract available


    February 2023
  11. CIECKO AE, Wang Y, Harleston S, Drewek A, et al
    Heterogeneity of Islet-Infiltrating IL-21+ CD4 T Cells in a Mouse Model of Type 1 Diabetes.
    J Immunol. 2023 Feb 10:ji2200712. doi: 10.4049/jimmunol.2200712.
    PubMed     Abstract available


    January 2023
  12. REYES J, Yap GS
    Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis.
    J Immunol. 2023;210:5-11.
    PubMed     Abstract available


    June 2022
  13. DWYER JR, Racine JJ, Chapman HD, Quinlan A, et al
    Nfkbid Overexpression in Nonobese Diabetic Mice Elicits Complete Type 1 Diabetes Resistance in Part Associated with Enhanced Thymic Deletion of Pathogenic CD8 T Cells and Increased Numbers and Activity of Regulatory T Cells.
    J Immunol. 2022 Jun 27. pii: jimmunol.2100558. doi: 10.4049/jimmunol.2100558.
    PubMed     Abstract available


  14. PODOJIL JR, Genardi S, Chiang MY, Kakade S, et al
    Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic beta Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice.
    J Immunol. 2022 Jun 20. pii: jimmunol.2200208. doi: 10.4049/jimmunol.2200208.
    PubMed     Abstract available


    March 2022
  15. BEN NASR M, Robbins D, Parone P, Usuelli V, et al
    Pharmacologically Enhanced Regulatory Hematopoietic Stem Cells Revert Experimental Autoimmune Diabetes and Mitigate Other Autoimmune Disorders.
    J Immunol. 2022 Mar 23. pii: jimmunol.2100949. doi: 10.4049/jimmunol.2100949.
    PubMed     Abstract available


  16. MELLANBY RJ, Koonce CH, Monti A, Phillips JM, et al
    Correction: Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes.
    J Immunol. 2022 Mar 2. pii: jimmunol.2200006. doi: 10.4049/jimmunol.2200006.
    PubMed    


  17. MAO QY, He SY, Hu QY, Lu Y, et al
    Advanced Glycation End Products (AGEs) Inhibit Macrophage Efferocytosis of Apoptotic beta Cells through Binding to the Receptor for AGEs.
    J Immunol. 2022;208:1204-1213.
    PubMed     Abstract available


    February 2022
  18. JIANG R, Qin Y, Wang Y, Xu X, et al
    Dynamic Number and Function of IL-10-Producing Regulatory B Cells in the Immune Microenvironment at Distinct Stages of Type 1 Diabetes.
    J Immunol. 2022 Feb 9. pii: jimmunol.2100357. doi: 10.4049/jimmunol.2100357.
    PubMed     Abstract available


    January 2022
  19. LOMBARD-VADNAIS F, Collin R, Daudelin JF, Chabot-Roy G, et al
    The Idd2 Locus Confers Prominent Resistance to Autoimmune Diabetes.
    J Immunol. 2022 Jan 17. pii: jimmunol.2100456. doi: 10.4049/jimmunol.2100456.
    PubMed     Abstract available


  20. JONES BE, Maerz MD, Bahnson HT, Somasundaram A, et al
    Fewer LAG-3(+) T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes.
    J Immunol. 2022 Jan 12. pii: jimmunol.2100850. doi: 10.4049/jimmunol.2100850.
    PubMed     Abstract available


    October 2021
  21. LI M, Itoh A, Xi J, Yu C, et al
    Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic Peptides.
    J Immunol. 2021;207:2051-2059.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.